Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Inonza 1mg Injection
Manufacturer/Marketed By : PFIZER LTD
$3294.38 $2635.50
Inonza 1mg injection is an anticancer medication with an active ingredient called Inotuzumab ozogamicin. It is used to treat adults with acute lymphoblastic Leukemia. It is intended when patients have...
Collapsible text is perfect for longer content like paragraphs and descriptions. It's a great way to give people more information while keeping your layout clean. Link your text to anything, including an external website or a different page. You can set your text box to expand and collapse when people click, so they can read more or less info.
INOTUZUMAB OZOGAMICIN
Active Pharmaceutical Ingredient
Inonza 1mg Injection
$3,294.38
$2,635.50
Inonza 1mg injection is an anticancer medication with an active ingredient called Inotuzumab ozogamicin. It is used to treat adults with acute lymphoblastic Leukemia. It is intended when patients have failed to respond to other treatments. Acute lymphoblastic Leukemia (ALL) refers to the accumulation of white blood cells that have not matured due to the abnormal production of white blood cells in the bone marrow. Do not take Inonza 1mg injection if you are allergic to Inotuzumab ozogamicin or any other ingredients of this medicine, if you have or have any history with any liver disease, such as venoocculusive disease (damaged liver blood vessels), cirrhosis, nodular regenerative hyperplasia (signs and symptoms of portal hypertension due to chronic use of medicine), or active hepatitis (inflammation of the liver) and blood clot. This medicine is not recommended for children and adolescents. Before starting the Inonza 1mg treatment, inform your doctor if you have signs and symptoms of tumour lysis syndrome, a low number of blood cells (neutrophils), elevations in amylase or lipase enzymes, or a history of QT interval prolongation. Notify your doctor if you are pregnant or planning to get pregnant during and after the treatment for up to 8 months. Use effective contraception during and after eight months of treatment for women and five months for men. Discuss with your doctor for more fertility concerns. Certain tests will be taken to monitor the blood cell count, liver enzyme, and QT interval.
Active Pharmaceutical Ingredient
Uses
• Acute lymphoblastic Leukemia
Benefits
Inotuzumab ozogamicin in Inonza 1mg injection targets a protein called CD22, which is commonly expressed by blood cancer (ALL) cells. After attaching to this protein, this medicine disturbs the DNA of the cancer cells and eventually kills them.
Side Effects
Side effects are unwanted symptoms caused by medicines. Even though all medications cause side effects, not everyone gets them.
Most Common Side Effects
• Anaemia
• Tiredness
• Infection
• Bleeding
• Fever
• Nausea
• Headache
• Abnormal blood values
• Stomach pain
• High bilirubin value
• Low appetite
• Mouth inflammation
• Constipation
• Diarrhea
• Swelling of abdomen
Common Side Effects
• Breathing trouble
• Chills
• Rapid weight gain
• Abnormal liver function values
• Frequent bleeding and bruising
• Infusion-related reaction (fever, chill, breathing trouble)
• Venoocclusive liver disease (rapid weight gain, right upper abdomen pain, swelling of the liver)
• The lower number of blood cells
• Tumor lysis syndrome
• Changes in the electrical activity of the heart
How To Use
A trained doctor or nurse should only administer it. Do not self-administer the Inonza 1mg injection. Your doctor will decide the dose and duration of your treatment based on the disease severity and other factors. It will be given as an intravenous infusion, and you will be monitored carefully for unwanted side effects.
Safety Advice
• Breast Feeding: It is unsafe to take Inonza 1mg Injection while breastfeeding. Before starting the treatment, notify your doctor if you are breastfeeding. Do not breastfeed during and at least after the two months of the last dose.
• Alcohol: It is unknown whether it is safe to consume alcohol with Inonza 1mg Injection as this medicine makes you feel drowsy. Please consult your doctor for more information.
• Liver: Inform your physician about any underlying liver disorders before taking Inonza 1mg Injection, as this medication should be used cautiously in liver disease patients. Consult your physician before taking this medicine.
• Lungs: It is unknown whether Inonza 1mg Injection is safe to administer in patients with lung problems. Inform your physician if you have any lung disease before starting the treatment. Contact your doctor if you experience any lung-related symptoms.
• Driving: Driving while taking Inonza 1mg Injection is unsafe because this medicine might tire you. So, avoid driving and operating machinery during this treatment.
• Pregnancy: Your doctor will prescribe Inonza 1mg Injection only if needed, as this medicine might cause harm to the unborn baby. So notify your doctor before starting the preganat if you are preganat or planning to get pregnant. It is advised for women to use contraception during and after the treatment for at least eight months.
Disclaimer
Sidmex Inovia strives to provide accurate and reliable information; however, all content on this website, including product descriptions and compositions, is for informational purposes only and should not be considered a substitute for professional medical advice, diagnosis, or treatment.
Users are advised to consult a qualified healthcare professional before making any medical decisions. The information provided should not be used for self-diagnosis or self-medication.
All products listed are intended strictly for B2B and bulk inquiry purposes only. Sidmex Inovia does not promote direct consumer use and aims to support, not replace, the healthcare professional–patient relationship.
Product names, trademarks, and brands belong to their respective owners, and their use does not imply any affiliation or endorsement. Sidmex Inovia shall not be held responsible for any consequences arising from the use of the information provided on this website.